000 01382 a2200373 4500
005 20250517051607.0
264 0 _c20160708
008 201607s 0 0 eng d
022 _a1531-703X
024 7 _a10.1097/CCO.0000000000000223
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGingras, Isabelle
245 0 0 _aLiquid biopsy: will it be the 'magic tool' for monitoring response of solid tumors to anticancer therapies?
_h[electronic resource]
260 _bCurrent opinion in oncology
_cNov 2015
300 _a560-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aBiomarkers, Tumor
_xblood
650 0 4 _aBiopsy
_xmethods
650 0 4 _aClinical Trials as Topic
650 0 4 _aDNA, Neoplasm
_xblood
650 0 4 _aHumans
650 0 4 _aMolecular Targeted Therapy
_xmethods
650 0 4 _aNeoplasms
_xblood
650 0 4 _aNeoplastic Cells, Circulating
650 0 4 _aPrognosis
650 0 4 _aProspective Studies
650 0 4 _aProto-Oncogene Proteins
_xgenetics
650 0 4 _aras Proteins
_xgenetics
700 1 _aSalgado, Roberto
700 1 _aIgnatiadis, Michail
773 0 _tCurrent opinion in oncology
_gvol. 27
_gno. 6
_gp. 560-7
856 4 0 _uhttps://doi.org/10.1097/CCO.0000000000000223
_zAvailable from publisher's website
999 _c25227907
_d25227907